GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » Interest Coverage

Essex Bio-Technology (HKSE:01061) Interest Coverage : 68.66 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Essex Bio-Technology's Operating Income for the six months ended in Dec. 2023 was HK$122 Mil. Essex Bio-Technology's Interest Expense for the six months ended in Dec. 2023 was HK$-2 Mil. Essex Bio-Technology's interest coverage for the quarter that ended in Dec. 2023 was 68.66. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Essex Bio-Technology's Interest Coverage or its related term are showing as below:

HKSE:01061' s Interest Coverage Range Over the Past 10 Years
Min: 17.08   Med: 31.47   Max: 154.93
Current: 27.8


HKSE:01061's Interest Coverage is ranked better than
63.93% of 671 companies
in the Drug Manufacturers industry
Industry Median: 12.55 vs HKSE:01061: 27.80

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Essex Bio-Technology Interest Coverage Historical Data

The historical data trend for Essex Bio-Technology's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Essex Bio-Technology Interest Coverage Chart

Essex Bio-Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.25 154.93 44.76 24.53 27.80

Essex Bio-Technology Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.00 31.97 19.46 20.11 68.66

Competitive Comparison of Essex Bio-Technology's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essex Bio-Technology's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's Interest Coverage falls into.



Essex Bio-Technology Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Essex Bio-Technology's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Essex Bio-Technology's Interest Expense was HK$-11 Mil. Its Operating Income was HK$312 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$56 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*311.681/-11.212
=27.80

Essex Bio-Technology's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, Essex Bio-Technology's Interest Expense was HK$-2 Mil. Its Operating Income was HK$122 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$56 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2023 )/Interest Expense (Q: Dec. 2023 )
=-1*121.939/-1.776
=68.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Essex Bio-Technology  (HKSE:01061) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Essex Bio-Technology Interest Coverage Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Essex Bio-Technology (HKSE:01061) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Executives
Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin 2101 Beneficial owner

Essex Bio-Technology (HKSE:01061) Headlines

No Headlines